Wright Carter A, Taylor Jared W, Cochran Meagan, Lawlor James M J, Moyers Belle A, Amaral Michelle D, Bonnstetter Zachary T, Carter Princess, Solomon Veronika, Myers Richard M, Love Marissa Natelson, Geldmacher David S, Cooper Sara J, Roberson Erik D, Cochran J Nicholas
HudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
University of Alabama in Huntsville, Huntsville, Alabama 35899, USA.
medRxiv. 2023 Feb 8:2023.02.06.23285383. doi: 10.1101/2023.02.06.23285383.
We collected and analyzed genomic sequencing data from individuals with clinician- diagnosed early-onset or atypical dementia. Thirty-two patients were previously described, with sixty-eight newly described in this report. Of those sixty-eight, sixty-two patients reported Caucasian, non-Hispanic ethnicity and six reported as African American, non-Hispanic. Fifty-three percent of patients had a returnable variant. Five patients harbored a pathogenic variant as defined by the American College of Medical Genetics criteria for pathogenicity. A polygenic risk score was calculated for Alzheimer's patients in the total cohort and compared to the scores of a late-onset Alzheimer's cohort and a control set. Patients with early-onset Alzheimer's had higher non- polygenic risk scores than patients with late onset Alzheimer's, supporting the conclusion that both rare and common genetic variation associate with early-onset neurodegenerative disease risk.
我们收集并分析了临床诊断为早发性或非典型痴呆症患者的基因组测序数据。之前已描述过32名患者,本报告中新描述了68名患者。在这68名患者中,62名报告为非西班牙裔白人,6名报告为非西班牙裔非裔美国人。53%的患者有可返回的变异。5名患者携带了根据美国医学遗传学学会致病性标准定义的致病变异。计算了整个队列中阿尔茨海默病患者的多基因风险评分,并与晚发性阿尔茨海默病队列和对照组的评分进行比较。早发性阿尔茨海默病患者的非多基因风险评分高于晚发性阿尔茨海默病患者,支持罕见和常见基因变异均与早发性神经退行性疾病风险相关的结论。